Advertisement

Allergic Contact Dermatitis

  • Danya Reich
  • Corinna Eleni Psomadakis
  • Bobby Buka
Chapter

Abstract

A 33-year-old male visited Primary Care after developing an erythematous and edematous macular rash in the periorbital area. The rash was diagnosed as allergic contact dermatitis (ACD). ACD is a T cell-mediated type IV hypersensitivity reaction that occurs after re-exposure to an allergen. Nickel, neomycin, thimerosal, formaldehyde, and fragrance mix are among the most common contact allergens. ACD is associated with occupational exposure to allergens and has a higher prevalence among salon workers, metal workers, and health care professionals. ACD may be treated with topical corticosteroids; however, allergen avoidance is the safest way to avoid recurrence.

Keywords

Allergy Occupational dermatitis Allergic contact dermatitis Skin allergy Allergen Irritant Edema Type 4 hypersensitivity Type IV hypersensitivity T Cell T Cell-mediated Allergic reaction Nickel Formaldehyde Thimerosal Cosmetics Patch testing Patch test Corticosteroid Prednisone 

References

  1. 1.
    Castanedo-Tardan M, Zug KA. Chapter 13. Allergic contact dermatitis. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine [internet]. 8th ed. New York: McGraw-Hill; 2012. Available from: http://accessmedicine.mhmedical.com.ezproxy.cul.columbia.edu/content.aspx?bookid=392&Sectionid=41138708. Accessed 12 Mar 2015.Google Scholar
  2. 2.
    Thyssen JP, Linneberg A, Menné T, Johansen JD. The epidemiology of contact allergy in the general population—prevalence and main findings. Contact Dermatitis. 2007;57(5):287–99.CrossRefPubMedGoogle Scholar
  3. 3.
    Pesonen M, Jolanki R, Larese Filon F, Wilkinson M, Kręcisz B, Kieć-Świerczyńska M, Bauer A, Mahler V, John SM, Schnuch A, Uter W, ESSCA network. Patch test results of the European baseline series among patients with occupational contact dermatitis across Europe—analyses of the European Surveillance System on Contact Allergy network, 2002–2010. Contact Dermatitis. 2015;72(3):154–63.CrossRefPubMedGoogle Scholar
  4. 4.
    Fyhrquist N, Lehto E, Lauerma A. New findings in allergic contact dermatitis. Curr Opin Allergy Clin Immunol. 2014;14(5):430–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Lundov MD, Moesby L, Zachariae C, Johansen JD. Contamination versus preservation of cosmetics: a review on legislation, usage, infections, and contact allergy. Contact Dermatitis. 2009;60(2):70–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Cohen DE, Heidary N. Treatment of irritant and allergic contact dermatitis. Dermatol Ther. 2004;17(4):334–40.CrossRefPubMedGoogle Scholar
  7. 7.
    Schlapbach C, Simon D. Update on skin allergy. Allergy. 2014;69(12):1571–81.CrossRefPubMedGoogle Scholar
  8. 8.
    Saary J, Qureshi R, Palda V, DeKoven J, Pratt M, Skotnicki-Grant S, Holness L. A systematic review of contact dermatitis treatment and prevention. J Am Acad Dermatol. 2005;53(5):845.CrossRefPubMedGoogle Scholar
  9. 9.
    Saripalli YV, Gadzia JE, Belsito DV. Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis. J Am Acad Dermatol. 2003;49(3):477–82.CrossRefPubMedGoogle Scholar
  10. 10.
    Katsarou A, Armenaka M, Vosynioti V, Lagogianni E, Kalogeromitros D, Katsambas A. Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis. J Eur Acad Dermatol Venereol. 2009;23(4):382–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Katsarou A, Makris M, Papagiannaki K, Lagogianni E, Tagka A, Kalogeromitros D. Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema a prospective randomized clinical study. Eur J Dermatol. 2012;22(2):192–6.PubMedGoogle Scholar
  12. 12.
    Usatine RP, Riojas M. Diagnosis and management of contact dermatitis. Am Fam Physician. 2010;82(3):249–55.PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Open Access This chapter is distributed under the terms of the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Authors and Affiliations

  • Danya Reich
    • 1
  • Corinna Eleni Psomadakis
    • 2
  • Bobby Buka
    • 3
  1. 1.Department of Family MedicineMount Sinai School of Medicine Attending Mount Sinai Doctors/Beth Israel Medical Group-WilliamsburgBrooklynUSA
  2. 2.School of Medicine Imperial College LondonLondonUK
  3. 3.Department of DermatologyMount Sinai School of MedicineNew YorkUSA

Personalised recommendations